CPHI & PMEC China, taking place this June at the Shanghai New International Expo Center, will bring together over 3,000 exhibitors and more than 55,000 attendees from over 110 countries. The event will cover 15 sectors across the pharmaceutical industry, providing a comprehensive platform for global pharma industry players. Jenny Leung, Regional Manager of Informa Markets, underscored the event’s role in fostering global partnering and meeting the growing international ingredients demand.
With a 25% improvement in China’s reputation for API manufacturing, the country now stands alongside leading European nations like Italy and France, according to the CPHI Annual Survey. As the world’s largest market for pharmaceutical ingredients and starting materials, CPHI & PMEC China presents immense opportunities for international collaboration and expansion.
In addition to the exhibition, the event will host over 80 conference sessions, the 12th China-World CEO Summit, the InnoPack Awards China, the China-World Innovation and Development Forum, and International Regulatory Agencies Updates. These sessions aim to foster collaboration, innovation, and networking among global pharmaceutical professionals. The Hosted Buyer Programme will also return, providing a targeted matchmaking service for international attendees seeking the most suitable domestic and regional suppliers, further enhancing international partnerships in the pharmaceutical sector.